ATE241980T1 - Neue inhalationspräparate enthaltend cr 2039 (andolast) - Google Patents

Neue inhalationspräparate enthaltend cr 2039 (andolast)

Info

Publication number
ATE241980T1
ATE241980T1 AT97830417T AT97830417T ATE241980T1 AT E241980 T1 ATE241980 T1 AT E241980T1 AT 97830417 T AT97830417 T AT 97830417T AT 97830417 T AT97830417 T AT 97830417T AT E241980 T1 ATE241980 T1 AT E241980T1
Authority
AT
Austria
Prior art keywords
andolast
preparations containing
pharmaceutically
inhalation preparations
new inhalation
Prior art date
Application number
AT97830417T
Other languages
English (en)
Inventor
Francesco Makovec
Paolo Senin
Lucio Claudio Rovati
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Application granted granted Critical
Publication of ATE241980T1 publication Critical patent/ATE241980T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT97830417T 1997-08-08 1997-08-08 Neue inhalationspräparate enthaltend cr 2039 (andolast) ATE241980T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97830417A EP0896821B1 (de) 1997-08-08 1997-08-08 Neue Inhalationspräparate enthaltend CR 2039 (Andolast)

Publications (1)

Publication Number Publication Date
ATE241980T1 true ATE241980T1 (de) 2003-06-15

Family

ID=8230753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97830417T ATE241980T1 (de) 1997-08-08 1997-08-08 Neue inhalationspräparate enthaltend cr 2039 (andolast)

Country Status (9)

Country Link
US (1) US5976576A (de)
EP (1) EP0896821B1 (de)
JP (1) JP4301598B2 (de)
AT (1) ATE241980T1 (de)
AU (1) AU735204B2 (de)
CA (1) CA2244357C (de)
DE (1) DE69722610T2 (de)
ES (1) ES2199336T3 (de)
PT (1) PT896821E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010709D0 (en) * 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
US7087631B2 (en) * 2002-07-18 2006-08-08 Inotek Pharmaceuticals Corporation Aryltetrazole compounds, and compositions thereof
US7078423B2 (en) * 2002-07-18 2006-07-18 Inotek Pharmaceuticals Corporation 5-Aryltetrazole compounds, compositions thereof, and uses therefor
US7037927B2 (en) * 2003-10-16 2006-05-02 Abbott Laboratories Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
CA2570386A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods of using albuterol and calcium activated potassium channel openers
WO2005123072A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods and compositions for the treatment of pulmonary diseases
EP1634595B1 (de) * 2004-08-19 2008-08-13 Rottapharm S.p.A. Verwendung von Phenylbenzamide-derivaten zur Behandlung von chronisch-obstruktiver Lungenerkrankung (COPD)
CA2635649A1 (en) * 2006-01-06 2007-07-12 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and andolast
EP1845093B1 (de) * 2006-04-10 2009-06-10 Rottapharm S.p.A. Neue kristalline und stabile Form von Andolast
PT2054057E (pt) * 2006-07-31 2011-05-05 Rottapharm Spa Combina??o de andolast/glucocortic?ides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
EP0625069B1 (de) * 1992-10-26 1998-12-30 Schwarz Pharma Ag Verfahren zur herstellung von mikrokapseln
US5453368A (en) * 1993-08-27 1995-09-26 Brown University Research Foundation Method of encapsulating biological substances in microspheres
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5741168A (en) * 1996-06-21 1998-04-21 Chen; Ming-Sheng Toy glider as folded and assembled from two-dimensional elements

Also Published As

Publication number Publication date
AU735204B2 (en) 2001-07-05
DE69722610T2 (de) 2004-04-29
ES2199336T3 (es) 2004-02-16
DE69722610D1 (de) 2003-07-10
PT896821E (pt) 2003-08-29
EP0896821A1 (de) 1999-02-17
CA2244357A1 (en) 1999-02-08
AU7732798A (en) 1999-02-18
EP0896821B1 (de) 2003-06-04
CA2244357C (en) 2007-05-01
JPH11106339A (ja) 1999-04-20
US5976576A (en) 1999-11-02
JP4301598B2 (ja) 2009-07-22

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
CA2295035A1 (en) Pharmaceutical formulations containing voriconazole
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
CA2335065A1 (en) Pharmaceutical formulations for aerosols with two or more active substances
DE69523438D1 (de) Orale metoprolol-dosisform des typs "einmal täglich"
EP1468679A3 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
ATE185792T1 (de) Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
CY1107966T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν μετφορμινη και γλιβενκλαμιδη για τη θεραπεια του σακχαρωδους διαβητη τυπου ii
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
BR9500758A (pt) Formulaçoes farmacêuticas para administraçao oral
DK581889A (da) Antiatherosclerotiske diarylforbindelser
DE69722610D1 (de) Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
EP0667163A4 (de) Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
DK0521393T3 (da) Dichlofenac-cholinsalt, fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder det
TR200001121T2 (tr) Antiromatizmal madde.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
SE9101687D0 (sv) Dikloranilinfoerening

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0896821

Country of ref document: EP

EEFA Change of the company name
REN Ceased due to non-payment of the annual fee